Viking Therapeutics (VKTX) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to -$1.1 million.
- Viking Therapeutics' Change in Account Payables rose 9002.31% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 17625.07%. This contributed to the annual value of $2.3 million for FY2024, which is 32622.79% up from last year.
- As of Q3 2025, Viking Therapeutics' Change in Account Payables stood at -$1.1 million, which was up 9002.31% from -$2.2 million recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Change in Account Payables registered a high of $9.6 million during Q4 2024, and its lowest value of -$10.8 million during Q3 2024.
- In the last 5 years, Viking Therapeutics' Change in Account Payables had a median value of -$637000.0 in 2021 and averaged $22421.1.
- As far as peak fluctuations go, Viking Therapeutics' Change in Account Payables surged by 56373.63% in 2022, and later tumbled by 1093500.0% in 2024.
- Over the past 5 years, Viking Therapeutics' Change in Account Payables (Quarter) stood at -$1.4 million in 2021, then soared by 487.55% to $5.4 million in 2022, then plummeted by 66.57% to $1.8 million in 2023, then skyrocketed by 430.87% to $9.6 million in 2024, then plummeted by 111.31% to -$1.1 million in 2025.
- Its last three reported values are -$1.1 million in Q3 2025, -$2.2 million for Q2 2025, and -$2.1 million during Q1 2025.